Article ID Journal Published Year Pages File Type
9327688 Gynecologic Oncology 2005 5 Pages PDF
Abstract
Conclusions. Weekly paclitaxel at a dose of 60 mg/m2 in combination with carboplatin at an AUC of 5 is well tolerated and active in potentially platinum-sensitive recurrent ovarian and peritoneal carcinoma.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma
Authors
, , ,